Discussing Psa: Clinical Response To Guselkumab & Sequential Lines Of B/Tsdmards

Discussing PsA: Clinical Response to Guselkumab & Sequential Lines of b/tsDMARDs

The Immune-Mediated Inflammatory Disease Forum

Discussing PsA: Guselkumab and analysis of genetic markers

The Immune-Mediated Inflammatory Disease Forum

PsA Podcast: Guselkumab & Secukinumab – All the Latest in Efficacy & Safety

The Immune-Mediated Inflammatory Disease Forum

COSMOS: Further evidence for the benefits of guselkumab in PsA | Laura Coates

Medicine Matters rheumatology

PsA Podcast: DISCOVER-2 and BE OPTIMAL/BE COMPLETE post-hoc analyses

The Immune-Mediated Inflammatory Disease Forum

How PSA Responds to #ProstateCancer Treatment | #MarkScholzMD #AlexScholz #PCRI

Prostate Cancer Research Institute

Elevated PSA: What Should You Do?

Dr. Tracy Gapin

Medication Review Video Module : How is Guselkumab dosed in PsO, PsA, and IBD

Efficacy and safety of guselkumab in patients with active psoriatic arthritis

Annals of the Rheumatic Diseases

Study Finds TREMFYA® Reduces Fatigue in PsA Patients

HPR

Ixekizumab vs. guselkumab in plaque psoriasis, A. Blauvelt et al

British Journal of Dermatology

Dr. Leonard Gomella Discusses PSA Velocity

Does High PSA Levels = Prostate Cancer? | Dr Steven Tucker

Screening for Prostate Cancer: PSA: Why 1.5 is the New 4

Grand Rounds in Urology

Tremfya (guselkumab): treatment for plaque psoriasis and psoriatic arthritis

Ixekizumab vs. guselkumab in plaque psoriasis, Blauvelt et al

British Journal of Dermatology

PsA Podcast: Gender differences in treating PsA & safety of guselkumab in treating PsO and PsA

The Immune-Mediated Inflammatory Disease Forum

PSA Screening | #ProstateCancer #MarkScholzMD #PCRI

Prostate Cancer Research Institute

Forward Progress in Molecular Markers for Prostate Cancer

Grand Rounds in Urology